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Tuberous sclerosis (TSC) is an autosomal dominant dis-
ease characterized by hamartoma formation in various
organs and is caused by mutations targeting either the
TSC1 or TSC2 genes. TSC1 and TSC2 proteins form a
functionally interdependent dimeric complex. Phosphor-
ylation of either TSC subunit by different kinases regu-
lates the function of TSC and represents a major mecha-
nism to integrate various signals into a centralized cell
growth pathway. The majority of disease-associated mu-
tations targeting either TSC1 or TSC2 results in a sub-
stantial decrease in protein level, suggesting that protein
turnover also plays a critical role in TSC regulation. Here
we report that TSC2 protein binds to FBW5, a DDB1-
binding WD40 (DWD) protein, and is recruited by FBW5
to the DDB1–CUL4–ROC1 E3 ubiquitin ligase. Overex-
pression of FBW5 or CUL4A promotes TSC2 protein deg-
radation, and this is abrogated by the coexpression of
TSC1. Conversely, depletion of FBW5, DDB1, or
CUL4A/B stabilizes TSC2. Ddb1 or Cul4 mutations in
Drosophila result in Gigas/TSC2 protein accumulation
and cause growth defects that can be partially rescued by
Gigas/Tsc2 reduction. These results indicate that FBW5–
DDB1–CUL4–ROC1 is an E3 ubiquitin ligase regulating
TSC2 protein stability and TSC complex turnover.
Received October 9, 2007; revised version accepted January
29, 2008.
The tuberous sclerosis 1 (TSC1) locus encodes a 130-kDa
protein termed “hamartin,” and the TSC2 locus encodes
a 180-kDa protein termed “tuberin” that contains a
coiled-coil domain and a GAP (GTPase-activating pro-
tein) domain. Genetic studies in Drosophila melanogas-
ter and biochemical analyses in mammalian cells have
established the TSC1–TSC2 heterodimeric complex as a
critical regulator in coupling various cellular conditions
to cell growth through stimulation of GTP hydrolysis of
RheB to antagonize the mTOR signaling pathway (Inoki
et al. 2005). These studies have identified both TSC sub-
units as substrates of various kinases that mediate dif-
ferent cellular conditions such as nutrient availability,
energy, hormones, and growth factor stimulation. TSC2
is a short-lived protein, and it is actively ubiquitinated
(Chong-Kopera et al. 2006). Many disease-associated mu-
tations in TSC1 and TSC2 result in a substantial de-
crease in the level of hamartin and tuberin, respectively
(Inoki et al. 2002; Nellist et al. 2005), suggesting that
protein turnover plays a critical role in TSC regulation.
Identification of the ubiquitin ligase for TSC2 would
shed light on the understanding of the regulation of TSC
and cell growth pathways.
Results and Discussion
TSC2 binds to WD40 protein FBW5, DDB1, and CUL4
We used a yeast two-hybrid screen and coupled immu-
noprecipitation and immunoblotting (IP-Western) analy-
ses to search for TSC2-interacting protein with potential
ubiquitin ligase activity and identified two F-box pro-
teins—FBW5 (Fig. 1A) and FBL6 (data not shown)—that
bind with TSC2. Three additional control F-box pro-
teins—SKP2, -TrCP, and FBX5—did not bind with
TSC2 in the same assay (data not shown), indicating
specificity of the FBL6–TSC2 and FBW5–TSC2 interac-
tions and also suggesting that the F-box motif is not suf-
ficient for binding to TSC2. Consistent with TSC1–
TSC2 dimerization, FBW5 also associates with TSC1
(Fig. 1A). Our subsequent genetic study in Drosophila
(see below) led us to focus on determining the function
and mechanism of the FBW5–TSC interaction. The func-
tional significance of the FBL6–TSC interaction remains
to be determined.
Human FBW5 is a 60-kDa (566 residues) protein con-
taining two recognizable domains; an N-terminally lo-
cated F-box motif and seven WD40 repeats occupying
most of the rest of the sequence. The F-box motif func-
tions to bridge a substrate protein to the CUL1–ROC1 E3
ligase via the SKP1 linker (Bai et al. 1996; Feldman et al.
1997; Skowyra et al. 1997). Recently, we and others
found that DDB1 binds to a subset of WD40 proteins
referred to as DWD proteins (also known as DCAF, for
Ddb1- and Cul4-associated factors; or CDW, for CUL4-
and DDB1-associated WD40 repeat proteins), and bridges
them to CUL4–ROC1 to constitute a potentially large
and distinct family of DWD–DDB1–CUL4–ROC1 E3
ubiquitin ligases (Angers et al. 2006; He et al. 2006; Higa
et al. 2006; Jin et al. 2006). FBW5 contains two recogniz-
able DWD boxes between residues 436 and 451 and 484
and 499 (He et al. 2006), which led us to determine
whether it can bind to and target TSC2 for ubiquitina-
tion by the DDB1–CUL4–ROC1 ligase.
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We first examined the association between ectopically
expressed TSC2 and DDB1–CUL4A complex in 293T
cells. TSC2, as well as its partner TSC1, was readily de-
tected in both DDB1 and CUL4A immunocomplexes
(Fig. 1B). Both TSC1 and TSC2 proteins were also readily
detected in CUL4A immunocomplexes from untrans-
fected 293T or U2OS cells (shown for 293T cells in Fig.
1C), demonstrating association between endogenous
TSC1–TSC2 and DDB1–CUL4A. The amount of TSC2
protein detected in CUL4A complexes is similar to or
slightly greater than that detected by direct Western
blotting using one-tenth of the cell extract, suggesting
that at least 10% of the total TSC2 is associated with
DDB1–CUL4A in 293T cells (Fig. 1C). We therefore con-
clude that the DDB1–CUL4 ligase plays a direct and im-
portant role in regulating the TSC complex in vivo.
To determine which domain—the F-box or the WD40
repeats—is required for FBW5 to bridge TSC1–TSC2 to
DDB1–CUL4A, we generated FBW5 mutants, FBW5F
and FBW5WD, with deletions of the F-box motif and
WD40 domain, respectively. The FBW5WD mutant
completely lost its ability to bind with TSC2 (Fig. 1D).
The FBW5F mutant cannot bind to SKP1 but retains the
ability to bridge TSC1 and TSC2 with DDB1–CUL4A
(Fig. 1E). These results demonstrate that the WD40 re-
peats, but not the F-box, in FBW5 mediate TSC2 binding
to DDB1, supporting the idea that a CUL4-, but not a
CUL1-based E3 ligase regulates TSC2 protein stability
(see below).
FBW5 promotes TSC2 degradation
To determine whether FBW5–DDB1–CUL4 is an E3
ubiquitin ligase for TSC2 and promotes TSC2 degrada-
tion, we coexpressed TSC2 with a series of individual
components of different E3 ubiquitin ligases. Overex-
pression of FBW5 substantially reduced the steady-state
level of ectopically expressed TSC2 protein, while over-
expression of another DWD protein, CDT2, or two F-box
proteins, SKP2 and FBL6, did not exhibit any detectable
effect on the level of TSC2 (Fig. 2A). In the same assay,
overexpression of CUL4A also reduced the level of TSC2
protein. Overexpression of ROC1 or DDB1 did not show
any effect on TSC2 levels, suggesting that a sufficient
amount of both proteins is present in the cells to support
the ligase activity toward TSC2. Overexpression of
CUL1 also noticeably reduced the level of TSC2, albeit
to a lesser extent than CUL4A overexpression. Consis-
tent with the notion that FBW5F is sufficient to bridge
TSC2 to DDB1–CUL4A, overexpression of FBW5F re-
duced TSC2 levels with a potency similarity to that of
wild type (Fig. 2B). Degradation of TSC2 by FBW5 or
FBW5F was inhibited by the proteasome inhibitor
MG132 (Fig. 2B), indicating that FBW5-promoted TSC2
degradation is proteasome-dependent. Coexpression of
Figure 2. Ectopic expression of FBW5 decreases TSC2. (A) HA-
tagged TSC2 was cotransfected with plasmids expressing various
indicated proteins into 293T cells. The steady-state level of TSC2
protein was determined by direct immunoblotting. (B) FBW5 pro-
motes TSC2 degradation in a proteasome-dependent manner. 293T
cells were cotransfected with plasmids expressing indicated proteins
and were either untreated or treated with proteasome inhibitor
MG132. The steady-state level of TSC2 protein was determined by
direct immunoblotting. (C) Coexpression of TSC1 protects TSC2
from degradation by FBW5. 293T cells were cotransfected with plas-
mids expressing indicated proteins, and the steady-state levels of
TSC1, TSC2, and FBW5 were determined by direct immunoblotting.
(D) A C-terminal domain of TSC2 is both required and sufficient for
FBW5-promoted degradation. Various TSC2 deletion mutants were
cotransfected with FBW5, and the steady-state level of TSC2 protein
was determined by direct immunoblotting.
Figure 1. FBW5 binds to both ubiquitin ligase DDB1–CUL4 and
TSC1–TSC2. (A,B) 293T cells were transfected with plasmids ex-
pressing the indicated proteins and protein–protein association was
examined by coupled IP-Western analysis. (C) Endogenous TSC2–
CUL4A association was determined by IP-Western analysis. (D) The
WD40 domain, but not the F-box, is required for bridging FBW5 to
associate with TSC2. 293T cells were transfected with plasmids
expressing HA3-TSC2 and Myc3-FBW5 or Myc3-FBW5 without ei-
ther the F-box or WD40 domain. The cells were lysed by NP-40
buffer, and the lysates were applied to IP with anti-HA antibody
followed by Western blot analysis with indicated antibodies. (E) The
F-box is not required for bridging FBW5 to associate with TSC1/2
and DDB1–CUL4A. 293T cells transfected with a plasmid express-
ing myc-tagged wild-type or mutant FBW5 deleting the F-box
(FBW5F), followed by IP-Western analysis to examine protein com-
plex formation.
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TSC1 protects TSC2 from degradation caused by FBW5
overexpression (Fig. 2C). This finding suggests that mo-
nomeric TSC2 is degraded by the FBW5–DDB1–CUL4–
ROC1 E3 ligase and suggests a molecular explanation for
why TSC2 function depends on the formation of a di-
meric complex with TSC1.
A series of deletion mutants of TSC2 was generated to
map the region in TSC2 required for its degradation by
FBW5–DDB1–CUL4A. All mutants containing amino
acids from 1321 to 1765 were effectively degraded by the
coexpression of FBW5, while all mutants missing this
fragment were resistant to FBW5-promoted degradation
(Fig. 2D). These results suggest that fragment 1321–1765
of TSC2, which contains the Rap-GAP domain and is
highly conserved during evolution, is necessary and suf-
ficient to mediate TSC2 degradation by the FBW5–
DDB1–CUL4 ligase.
Depletion of FBW5, DDB1, or CUL4A/B stabilizes
TSC2
To further demonstrate the function of FBW5, DDB1,
and CUL4A/B in targeting TSC2 protein degradation, we
blocked new protein synthesis with cycloheximide treat-
ment and determined the half-life of TSC2 protein. TSC2
is a short-lived protein with a half-life ∼2 h in control
U2OS cells transfected with scrambled siRNA oligo (Fig.
3A). Silencing either DDB1 or the combination of
CUL4A and CUL4B increased the half-life of TSC2 to >8
h (the duration of the experiment), and silencing FBW5
increased the half-life of TSC2 protein to ∼6 h (Fig. 3A).
Silencing CUL4, DDB1, or FBW5 also consistently sta-
bilized the half-life of ectopically expressed HA-TSC2,
measured by 35S pulse-chase assay (Fig. 3B). These re-
sults suggest that FBW5–DDB1–CUL4 is an active E3
ubiquitin ligase that continuously ubiquitinates TSC2
and promotes its degradation.
FBW5–DDB1–CUL4 promotes TSC2 in vivo
and in vitro ubiquitination
We next determined whether the FBW5–DDB1–CUL4–
ROC1 ligase ubiquitinates TSC2. U2OS cells were co-
transfected with plasmids expressing HA-tagged TSC2
and Flag-tagged ubiquitin, and 12 h later, the cells were
transfected with siRNA oligo silencing DDB1, FBW5, or
a combination of CUL4A/B. TSC2 in vivo ubiquitina-
tion in these cells was analyzed by measuring the
amount of HA-TSC2–Flag-ubiquitin conjugates by IP-
Western. TSC2 protein is actively ubiquitinated, and the
level of TSC2 ubiquitination was substantially reduced
by knocking down individually FBW5, DDB1, or
CUL4A/B, with FBW5 knockdown exhibiting the most
pronounced effect (Fig. 4A).
To demonstrate that the FBW5–DDB1–CUL4–ROC1
ligase directly promotes TSC2 ubiquitination in vitro,
we immunoprecipitated CUL4A complexes from trans-
fected 293T cells and used it as a source of E3 ligase.
Incubation of purified GST-TSC2 substrate with CUL4A
and FBW5 immunocomplexes resulted in robust TSC2
polyubiquitination in the presence of E1, E2-UBC5, ubiq-
uitin, and ATP (Fig. 4B, lane 1). Omitting either CUL4A
(Fig. 4B, lane 3) or FBW5 (Fig. 4B, lane 5) or substitution
of FBW5 with FBL6 (Fig. 4B, lane 2) abolished GST-TSC2
polyubiquitination. To further confirm GST-TSC2 ubiq-
uitination by the FBW5–DDB1–CUL4A–ROC1 ligase,
we performed dropped out experiments (Fig. 4C). Omit-
ting individually E1 (Fig. 4C, lane 3), E2-UBC5 (Fig. 4C,
lane 4), ATP (Fig. 4C, lane 5), and ubiquitin (Fig. 4C, lane
6) each eliminated GST-TSC2 polyubiquitination. Con-
sistent with the finding that the F-box motif is not re-
quired for mediating TSC2 ubiquitination by DDB1–
Figure 3. Silencing CUL4, DDB1, or Fbw5 stabilizes TSC2. (A) Si-
lencing DDB1, FBW5, or a combination of CUL4A and CUL4B in
mammalian cells increases the half-life of endogenous TSC2 pro-
tein. U2OS cells transfected with siRNAs targeting the indicated
genes were treated with cycloheximide for different times. The
steady-state level of endogenous TSC2 as well as TSC1 was deter-
mined by direct immunoblotting. (B) Silencing DDB1, FBW5, or a
combination of CUL4A and CUL4B in mammalian cells increases
the half-life of ectopic TSC2 protein. U2OS cells were transfected
with siRNAs targeting the indicated genes 12 h after transfection of
plasmid expressing HA-TSC2. The half-life of HA-STC2 was mea-
sured by 35S pulse-chase assay.
Figure 4. In vivo and in vitro ubiquitination of TSC2 by FBW5–
DDB1–CUL4 ligase. (A) CUL4, DDB1, and FBW5 are required for
TSC2 ubiquitination in vivo. U2OS cells were cotransfected with
plasmids expressing HA-TSC2 and Flag-ubiquitin and siRNA target-
ing CUL4A/B, DDB1, or FBW5. Cells were lysed 24 h after transfec-
tion, and TSC2 ubiquitination was analyzed by immunoprecipitat-
ing HA-TSC2 and blotted with an antibody recognizing Flag. (B) In
vitro ubiquitination of TSC2 by FBW5 and CUL4A. 293T cells were
cotransfected with plasmids expressing the indicated myc-tagged
proteins. Individual protein complex was eluted by incubating with
molar excess myc antigen peptide and mixed as indicated with sub-
strate GST-TSC2 in the presence of E1, E2, ubiquitin, and ATP.
Reaction mixtures were incubated for 30 min, terminated by boiling
directly in SDS sample buffer, resolved by SDS-PAGE, and immu-
noblotted with indicated antibodies. (C) Drop-out assay was carried
out as described in B to determine the specificity of in vitro TSC2
ubiquitination.
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CUL4A, FBW5F was fully capable of substituting for
wild-type FBW5 in promoting TSC2 ubiquitination (Fig.
4C, lane 2). Together, these results demonstrate that
FBW5 recruits TSC2 to the DDB1–CUL4A–ROC1 ligase
for polyubiquitination in vitro.
Drosophila Cul4 or Ddb1 mutants accumulate
Gigas/TSC2
To seek further in vivo evidence for FBW5–DDB1–
CUL4-mediated TSC2 degradation, we turned to D. me-
lanogaster in which both the TSC-mediated cell growth
control pathway and the DDB1–CUL4 E3 ligase are con-
served. Drosophila also contains a gene, CG9144, encod-
ing an F-box and WD40 protein that exhibits 40% iden-
tity and 58% similarity to human FBW5, and thus rep-
resents an FBW5 homolog. We first ectopically expressed
these three fly proteins in cultured S2 cells and exam-
ined their binding by coimmunoprecipitation assay. As
shown in Figure 5A, Flag-Gigas/TSC2 was readily de-
tected in Myc-dDDB1 (lane 3), HA-dDDB1 (lane 4), and
HA-dFBW5 immunocomplexes (lane 5), and Myc-dDDB1
complexes contained detectable Flag-Gigas/TSC2 and
HA-dFBW5 (lane 7). These results demonstrate that like
its mammalian homologs, Drosophila TSC2/Gigas also
bind directly to FBW5 and DDB1.
We then generated and characterized an antibody to
the Drosophila TSC2 protein, Gigas, and determined the
steady-state level of Gigas/TSC2 protein in cultured S2
cells after silencing dFbw5, dCul4, and dDdb1. The
specificity of this newly generated Gigas/TSC2 antibody
was verified by its recognition of bacterially produced
GST-Gigas fusion protein (Fig. 5B) and by the detection
of endogenous Gigas/TSC2 that was reduced in cells
transfected with dsRNA silencing Gigas (Fig. 5C). Silenc-
ing of dFbw5, dCul4, or dDdb1 all led to accumulation of
Gigas/TSC2 (Fig. 5C). We next generated and character-
ized a series of mutations in the single Cul4 and Ddb1
genes (S. Zacharek, Y. Xiong, and R. Ruronio, unpubl.).
Cul46AP and Cul411L were generated by P-element-me-
diated excision mutagenesis and encode predicted pro-
teins containing C-terminal deletions of 82 and 65
amino acids, respectively. Cul411L produces no protein
and is therefore null, while Cul46AP produces a sta-
ble truncated protein (Fig. 5D). Ddb1S026316 and
Ddb1EY01408 are P-element insertion-null alleles that
produce no detectable protein (Fig. 5D). The steady-state
level of Gigas/TSC2 was substantially increased in both
dCul46AP/6AP (Fig. 5D, lane 2) and dCul411L/6AP (Fig. 5D,
lane 3) mutant larvae as well as in dDdb1S02/EY mutant
larvae (Fig. 5D, lane 4). Together, these results demon-
strate, in both cultured cells and animals, that the
FBW5–DDB1–CUL4 E3 ligase is functionally conserved
in Drosophila in promoting TSC2 degradation. We noted
that while CUL4 and DDB1 promote TSC2 degradation
in both mammalian and Drosophila cells, loss of func-
tion of either CUL4 or DDB1 results in an increase of
steady-state levels of Gigas/TSC2 in fly cells, but not in
mammalian cells, raising an intriguing possibility that
there may exist an additional negative feedback loop in
human cells, possibly via a post-transcriptional control,
to maintain the TSC2 protein level.
Loss of Drosophila Ddb1 results in growth defects that
are alleviated by a reduction of Tsc2/Gigas
Notably, both Cul4- and Ddb1-null mutations cause
growth arrest in the first (Cul4) or second (Ddb1) instar
larvae, with the larvae capable of surviving for >10 d on
rich medium without growing (Fig. 5E). These results
reveal a previously unrecognized function of Ddb1 and
Cul4 in cell growth control. We next isolated and char-
acterized viable Ddb1 hypomorphic alleles that cause
growth defects and determined by complementation
analysis that a previously defined locus termed piccolo
(pic) was allelic to Ddb1. Semilethal piccolo mutants
were originally characterized based on shared irregulari-
ties in bristle, wing, and tergite growth (Rushlow and
Chovnick 1984; Clark and Chovnick 1985, 1986). This
type of growth defect is reminiscent of phenotypes ob-
Figure 5. Accumulation of Gigas/Tsc2 protein and growth defects
in Drosophila Cul4 and Ddb1 mutants. (A) Drosophila S2 cells were
transfected with plasmids expressing the indicated proteins, and
protein–protein association was examined by coupled IP-Western
analysis. (B) Characterization of an anti-Gigas antibody. Escherichia
coli BL21 cells were transformed with a plasmid expressing a
C-terminal portion of the Gigas protein, and were cultured in LB
media with or without IPTG to induce the expression of GST-Gigas.
Cells were lysed in SDS buffer followed by Western analysis. (C) S2
cells were treated with dsRNA targeting Gigas, dFbw5, dCul4, and
dDdb1 and control dsRNA for 2 d. The cells were lysed in RIPA
buffer followed by Western analysis with the indicated antibodies.
(D) Gigas accumulates in Drosophila Cul4 and Ddb1 mutants. Total
cell lysates were prepared from Drosophila Cul4 and Ddb1 mutant
first instar larvae, and the steady-state levels of Cul4, Ddb1, Giags,
tubulin, and phospho-S6K proteins were determined by direct West-
ern blotting. (E) Size comparison of growth-arrested Cul411L/11L ho-
mozygous mutant larvae with a normal Cul411L/+ heterozygous sib-
ling third instar larvae. (F) Drosophila hypomorphic Ddb1 mutants
display small and missing macrochaete. Scanning electron micro-
graphs of wild-type, Minute, and Ddb1pic2/PL12C mutant adults. (G)
Growth defects of Cul4 and Ddb1 mutants are rescued by hetero-
zygosity of gig (TSC2). Total eclosed flies and mean eclosion time of
Ddb1pic2/Ddb1PL12c mutants and their siblings and Ddb1pic2gig192/
Ddb1PL12c mutants and their siblings were measured at 18°C and
25°C.
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served in hypomorphic myc mutants and Minute mu-
tants, which are heterozygous for null alleles of ribo-
somal protein genes (Fig. 5F). pic2 is an X-ray-induced
hypomorphic allele of Ddb1 encoding a G21 → D sub-
stitution that results in severely reduced Ddb1 protein
levels (S. Zacharek, Y. Xiong, and R. Ruronio, unpubl.).
We generated another hypomorphic allele of Ddb1
(Ddb1PL12c) by excision of the Ddb1EY01408 P element
located in the 5 untranslated region. Ddb1pic2/PL12c mu-
tants develop into viable adults, but these flies show a
significant developmental delay and eclose on average 2
and 4 d later than control siblings at 25°C and 18°C,
respectively (Fig. 5G). In addition, these flies have cuticle
defects including missing bristles and small bristles that
resemble Min mutants (the piccolo phenotype) (Fig. 5F).
Reduction of Gigas/Tsc2 gene dose by half substantially
suppressed the late eclosion phenotype and the semile-
thality of Ddb1pic2/PL12c mutants (Fig. 5G), providing ge-
netic support that Tsc2 is a downstream target of Ddb1.
The bristle defects caused by Ddb1 mutation, on the
other hand, were not significantly alleviated by the Tsc2/
Gigas heterozygosity. This suggests that Tsc2 accumu-
lation contributes to some of the growth defects caused
by Ddb1 mutations and that Ddb1–Cul4 E3 ligases may
regulate additional substrates that are involved in cell
growth control.
In this study, we provide five lines of evidence indi-
cating that the FBW5–DDB1–CUL4–ROC1 ubiquitin li-
gase promotes the ubiquitination and degradation of the
TSC2 tumor suppressor. First, CUL4, DDB1, and FBW5
associate with TSC1 and TSC2. Second, overexpression
of FBW5 and CUL4A decreases the ectopically expressed
TSC2 in cultured mammalian cells. Third, depletion of
CUL4, DDB1, or FBW5 increases the half-life of TSC2 in
cultured mammalian cells by RNAi and the steady-state
levels in cultured Drosophila cells. Fourth, CUL4,
DDB1, and FBW5 are required for the ubiquitination of
TSC2 in vivo and in vitro. Finally, Drosophila Ddb1 hy-
pomorphic alleles accumulate Gigas/Tsc2 protein and
cause growth defects that can be rescued by reduction of
Gigas/Tsc2 gene dose by half. It has been previously re-
ported that the HERC1 ubiquitin ligase may contribute
to TSC2 degradation (Chong-Kopera et al. 2006). While
both HERC1 and FBW5–DDB1–CUL4–ROC1 E3 ligases
promote TSC2 degradation in mammalian cells, there is
no recognizable HERC1 homolog in Drosophila. This in-
dicates that the FBW5–DDB1–CUL4–ROC1 E3 ligase
was first evolved to regulate TSC2, and HERC1 was
evolved later and used by the mammalian cells to pro-
vide an additional regulation of TSC2.
The TSC1–TSC2 complex plays a key role in mediat-
ing the PI3K–mTOR pathway of cell growth control (En-
gelman et al. 2006). Recent studies have demonstrated
that TSC activity is regulated by as many as five other
kinases: AKT, GSK3, AMPK, RSK, ERK, and MAP-
KAPK2 upon various signals including mitogenic stimu-
lation, energy level, and amino acid availability (Crino et
al. 2006). The physiological condition(s) signaling FBW5
to promote TSC2 protein turnover by DDB1–CUL4 li-
gase remains to be elucidated. We speculate that FBW5–
DDB1–CUL4–ROC1 may function to regulate the ho-
meostasis of TSC complexes instead of mediating a spe-
cific cellular growth condition. TSC2 is a short-lived
protein undergoing constant turnover during normal cell
growth conditions (t1/2 < 2 h) (Fig. 3). By maintaining a
dynamic regulation of TSC complexes, cells can ensure
continued responsiveness of TSC complexes to different
growth conditions and signaling pathways. One way to
achieve this is to limit the lifetime of TSC2 subunit and
thus of TSC1–TSC2 complex, thereby avoiding locking
TSC complexes in a specific state by an individual sig-
naling growth condition.
Materials and methods
Plasmids, cell culture, and cell transfection
Plasmids expressing GFP, SKP1, SKP2, CUL1, CUL2, CUL3, CUL4A,
CUL5, ROC1, CAND1, and DDB1 were described previously (Michel and
Xiong 1998; Hu et al. 2004). Plasmids expressing CDT2 and myc3-ubiq-
uitin were obtained from collaborator Hui Zhang (Yale University, CT).
Plasmids expressing Flag-ubiquitin and TSC1, TSC2, and TSC2 mutants
were obtained from Kun-Liang Guan (University of Michigan at Ann
Arbor, MI). Plasmids expressing FBW5 and FBL6 were cloned from a HeLa
cDNA library. Mutations were introduced by site-directed mutagenesis
using the QuickChange Kit (Stratagene) and were verified by DNA se-
quencing. All human cells were cultured in DMEM containing 10% FBS
in a 37°C incubator with 5% CO2. Cell transfections were performed
using a calcium-phosphate buffer.
Antibodies, proteins, and immunological procedures
Antibodies to hemagglutinin (HA) (12CA5; Boehringer-Mannheim), Myc
(9E10; NeoMarker), T7 (Novagen), and Flag (M2; Sigma) were purchased
commercially. Antibodies to CUL4A, DDB1, ROC1, CAND1, TSC1, and
TSC2 were described previously (Shumway et al. 2003; Hu et al. 2004;
Zacharek et al. 2005). Polyclonal antibody to Gigas was raised against the
C-terminal epitope of Gigas protein (DMDDQRGDFIKYT). Procedures
for protein purification, immunoprecipitation, and immunoblotting have
been described (Ohta et al. 1999; Furukawa et al. 2003; Hu et al. 2004).
RNAi
All siRNA oligonucleotides were synthesized with 3 dTdT overhangs by
Dharmacon in a purified and annealed duplex form. The sequences tar-
geting each human gene were as follows: DDB1, 5-CCUGUUGAUUGC
CAAAAAC-3; CUL4A, 5-GAACUUCCGAGACAGACCU-3; Cul4B,
5-AAGCCUAAAUUACCAGAAA-3; Fbw5, 5-CCAAGGAGGGC
UUGCGGCACUUUCU-3. OPTI-MEM medium (500 µL) was mixed
with Lipofectamine 2000 reagent (10 µL) for 5 min and then incubated
with 10 µL (20 mM) of siRNA for 20 min at room temperature. DMEM-
10%-FBS medium (1.5 mL) was added to the mixture, and the entire 2.5
mL was added to HeLa cells cultured on a 60-mm plate at 30%–40%
confluency. The cells were transfected once with siRNAs and analyzed
48–72 h after transfection.
The RNAi in Drosophila S2 cells followed the protocol developed by
the Jack Dixon laboratory (http://cmm.ucsd.edu/Lab_Pages/Dixon/pro-
tocols.php). The Ambion Megascript T7 kits were used to generate the
dsRNAs targeting the first 500 bases of dCul4, dDdb1, and dFbw5 genes.
Eighty percent confluent S2 cells cultured in 35-mm dishes were added
with 5 µg of dsRNAs and incubated for 2 d. The dsRNA-treated S2 cells
were lysed in RIPA buffer and applied to Western blot analysis.
35S pulse-chase assay
Forty-eight hours after siRNA transfection, the medium was aspirated
off, and the cells were washed once with prewarmed PBS. Three millili-
ters of prewarmed labeling medium (DMEM, without Met and Cys, with
10% dialyzed FBS; ICN, Inc.) were added into each P100 dish. The cells
were incubated for 30 min at 37°C to deplete the intracellular pools of
sulfur-containing amino acids. 35S-Met (0.5 mCi) was added into each
P100 dish, and the cells were incubated for 4 h. Labeling medium con-
taining 35S-Met was then removed, and the cells were washed once with
prewarmed PBS followed by the addition of DMEM medium with 10%
FBS. The cells were lysed every 2 h and applied for IP using anti-HA
antibodies. The immunocomplexes were resolved by SDS-PAGE. The gel
was dried for 1 h at 80°C and developed by autoradiography. Each time
point was repeated three times.
Ubiquitination assays
For in vivo ubiquitination assay, the U2OS cells transfected with plas-
mids expressing HA3-TSC2 and Flag-ubiquitin were further transfected
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with siRNAs targeting Fbw5, DDB1, or CUL4A + CUL4B, or scrambled
siRNA 12 h later. The cells were lysed with SDS lysis buffer (50 mM
Tris-HCl at pH 8.0, 100 mM NaCl, 2% Triton X-100, 1% SDS) 48 h after
siRNA transfection, and then the lysates were diluted with 10× NP-40
buffer (50 mM Tris-HCl at pH 7.5, 150 mM NaCl, 0.5% NaCl, 50 mM
NaF). The diluted lysates were applied to immunoprecipitation with
anti-HA antibody and immunoblotting with anti-Flag antibody.
For the in vitro ubiquitination assay, the procedures for ubiquitin la-
beling were as described (Liu et al. 2002; Furukawa et al. 2003; Hu et al.
2004). Briefly, to purify substrate, GST-TSC2 was ectopically expressed
in 293T cells, extracted in RIPA lysis buffer (50 mM Tris-HCl at pH 8.0,
150 mM NaCl, 1% NP-40, 0.5% DOC, 0.1% SDS), and pulled down with
glutathione Sepharose 4B beads (Amersham Biosciences) followed by 10
mM glutathione elution. To purify CUL4A, CUL1, FBL6, and FBW5 li-
gases, Myc3-CUL4A, Myc3-CUL1, Myc3-FBL6, and Myc3-FBW5 immu-
nocomplexes were immunoprecipitated using anti-Myc antibody from
transfected 293T cells, immobilized on protein A-agarose beads, and
washed three times with an NP-40 buffer (50 mM Tris-HCl at pH 7.5, 150
mM NaCl, 0.5% NaCl, 50 mM NaF) and twice with a ligase assay buffer
(25 mM Tris-HCl at pH 7.5, 50 mM sodium chloride, 1 mM EDTA,
0.01% NP-40, 10% glycerol). Immobilized immunocomplexes were
eluted by incubating with a molar excess of Myc peptide. For the in vitro
TSC2 ubiquitination, the different combinations of CUL4A, CUL1,
Fbw5, and Fbl6 immunocomplexes were mixed with GST-TSC2 sub-
strate, and the mixtures were added to an ubiquitin ligation reaction
(final volume 30 µL) containing the following: 50 mM Tris-HCl (pH 7.4),
5 mM MgCl2, 2 mM sodium fluoride, 10 nM okadaic acid, 2 mM ATP,
0.6 mM dithiothreitol, 12 µg of bovine ubiquitin, 1 µg of ubiquitin
(Sigma), 60 ng of E1, and 300 ng of E2 (hUbc5c). Reactions were incubated
for 60 min at 30°C, terminated by boiling for 5 min in an SDS sample
buffer containing 0.1 M dithiothreitol, and resolved on an SDS-PAGE gel
before immunoblotting with the anti-GST antibody to examine ubiqui-
tin ladder formation.
Drosophila mutants
Cul411L, Cul46AP, and Ddb1PL12c alleles were generated by imprecise
excision of the P element in Cul4EP2518 and Ddb1EY01408 chromosomes,
respectively, and will be described in detail elsewhere. The Cul4EP2518,
Ddb1pic2, Ddb1S026316, and Ddb1EY01408 alleles were obtained from the
Bloomington Stock Center. gig192 was a kind gift of D.J. Pan.
Quantification of mean eclosion day and percentage of eclosed flies
DDB1PL12c/TM3 Sb, Ser P[act-GFP] females were crossed to either
DDB1pic2/TM3 Sb, Ser P[act-GFP] or DDB1pic2 gigas/TM3 × DDB1pl12c/
TM3 males, and Ddb1 mutant and heterozygous sibling progeny were
counted. For mean eclosion day calculations, the first day any fly from
the culture eclosed established day 1, and the genotype of all flies was
scored each day for nine and 12 successive days at 25°C and 18°C, re-
spectively. The experiment was performed in triplicate. A 95% Confi-
dence Interval test was used to obtain the range of the true mean of the
combined data at each temperature. A two-tailed t-test assuming un-
equal variances was used to compare eclosion day data between different
genotypes. The percentage of eclosed flies was calculated using the com-
bined data at each temperature, and different genotypes were compared
using a Fisher’s exact test.
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